Since the myeloid marker gene Lyz2 targets both macrophages and microglia, the observed consequence of exacerbated amyloidosis from the current study were possibly attributed to the deficiency of Arg1 in both brain resident microglia and CNS infiltrated macrophages. The gene discussed is ARG1; the disease is amyloidosis.